Journals

Cancer Care Spending and Use by Site of Provider-Administered Chemotherapy in Medicare
The American Journal of Managed Care > June 2019
Andrew Shooshtari, BS; Yamini Kalidindi, MHA; and Jeah Jung, PhD
Understanding Price Growth in the Market for Targeted Oncology Therapies
The American Journal of Managed Care > June 2019
Jesse Sussell, PhD; Jacqueline Vanderpuye-Orgle, PhD; Diana Vania, MSc; Hans-Peter Goertz, MPH; and Darius Lakdawalla, PhD
Reports of the Demise of Chemotherapy Have Been Greatly Exaggerated
The American Journal of Managed Care > June 2019
Bruce Feinberg, DO; Jonathan Kish, PhD, MPH; Igoni Dokubo, MD; Jeff Wojtynek, PharmD; and Kevin Lord, PhD, MHS
Making an Evidence-Based Case for Urgent Action to Address Clinician Burnout
The American Journal of Accountable Care > June 2019
Bernadette Mazurek Melnyk, PhD, APRN-CNP
Advancements in Follicular Lymphoma Treatment: Where We Are and Where We Are Going A Q&A With Andrew M. Evens, DO, MSc
Supplements > Targeting the PI3K Pathway in Follicular Lymphoma
Evolving Population Health Strategies for an Expanding Treatment Spectrum A Q&A With Sheila M. Arquette, RPh
Supplements > Targeting the PI3K Pathway in Follicular Lymphoma
Reducing Low-Value Care May Mean Tough Conversations With Stakeholders
The American Journal of Accountable Care > June 2019
Laura Joszt, MA
Language Matters: Talking About Low-Value Healthcare With Patients
The American Journal of Accountable Care > June 2019
Gwen Darien, BA, Executive Vice President, Patient Advocacy and Engagement, National Patient Advocate Foundation and Patient Advocate Foundation
Curtailing Utilization of Low-Value Medical Care
The American Journal of Accountable Care > June 2019
John P. Keats, MD, National Medical Director for Affordability and Specialty Partnerships, Cigna
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.